Search

Your search keyword '"Murillas, J."' showing total 142 results

Search Constraints

Start Over You searched for: Author "Murillas, J." Remove constraint Author: "Murillas, J."
142 results on '"Murillas, J."'

Search Results

1. Rhodomyrtone decreases Staphylococcus aureus SigB activity during exponentially growing phase and inhibits haemolytic activity within membrane vesicles

2. Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: the experience of the PISCIS Cohort

3. Clinical progression of severely immunosuppressed HIV-infected patients depends on virological and immunological improvement irrespective of baseline status

7. Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin

9. Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010-2015

10. Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort

15. Rhodomyrtone decreases Staphylococcus aureus SigB activity during exponentially growing phase and inhibits haemolytic activity within membrane vesicles

18. Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study

19. Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV–HCV co-infected patients: final results of the Spanish BOC HIV–HCV Study

20. Differential body composition effects of protease inhibitors recommended for initial treatment of HIV infection: a randomized clinical trial

21. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

22. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

23. 'Third day intervention': An analysis of the factors associated with following the recommendations on the prescribing of antibiotics

24. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

25. Influence of age on clinical presentation of acute pulmonary embolism

26. Clinical characteristics, treatment and outcomes of MRSA bacteraemia in the elderly

27. Metabolic effects of atazanavir/ritonavir vs darunavir/ritonavir in combination with tenofovir/emtricitabine in antiretroviral-na ve patients (ATADAR Study)

29. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study

30. Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

31. Direct‐acting antivirals are effective and safe in HCV/HIV‐coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

32. Prevalence of and risk factors for pulmonary abnormalities in HIV‐infected patients treated with antiretroviral therapy

33. Atorvastatin for protease inhibitor-related hyperlipidaemia

35. [Pyogenic liver abscess. A descriptive study of 35 cases]

36. Metabolic effects of atazanavir/ritonavir vs darunavir/ritonavir in combination with tenofovir/emtricitabine in antiretroviral-naïve patients (ATADAR Study)

37. HIV-1 infected patients older than 50 years. PISCIS cohort study

39. Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRS A: protocol of a multicentre, randomised, phase III trial.

41. Heat flow in the Valencia trough: Geodynamic implications

43. Encefalopatía tóxica por isoniacida

45. Heat flow in the Valencia trough: Geodynamic implications

Catalog

Books, media, physical & digital resources